Bharati R Dhruva
Examiner (ID: 3913)
Most Active Art Unit | 1632 |
Art Unit(s) | 1632 |
Total Applications | 2 |
Issued Applications | 1 |
Pending Applications | 1 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 7316680
[patent_doc_number] => 20040223953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'Combined adeno-associated virus and adenovirus cocktail gene delivery system for high efficiency gene expression without eliciting immune response in immuno-competent subjects'
[patent_app_type] => new
[patent_app_number] => 10/801648
[patent_app_country] => US
[patent_app_date] => 2004-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 17935
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0223/20040223953.pdf
[firstpage_image] =>[orig_patent_app_number] => 10801648
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/801648 | Combined adeno-associated virus and adenovirus cocktail gene delivery system for high efficiency gene expression without eliciting immune response in immuno-competent subjects | Mar 16, 2004 | Abandoned |
Array
(
[id] => 5219796
[patent_doc_number] => 20070161107
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-12
[patent_title] => 'Differentiation of human embryonic stem cells to cardiomyocytes'
[patent_app_type] => utility
[patent_app_number] => 10/548501
[patent_app_country] => US
[patent_app_date] => 2004-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8477
[patent_no_of_claims] => 84
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20070161107.pdf
[firstpage_image] =>[orig_patent_app_number] => 10548501
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/548501 | Differentiation of human embryonic stem cells to cardiomyocytes | Mar 10, 2004 | Abandoned |
Array
(
[id] => 7264987
[patent_doc_number] => 20040242523
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Chemo-inducible cancer gene therapy'
[patent_app_type] => new
[patent_app_number] => 10/795090
[patent_app_country] => US
[patent_app_date] => 2004-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 28048
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0242/20040242523.pdf
[firstpage_image] =>[orig_patent_app_number] => 10795090
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/795090 | Chemo-inducible cancer gene therapy | Mar 4, 2004 | Abandoned |
Array
(
[id] => 5984771
[patent_doc_number] => 20110097385
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-28
[patent_title] => 'Delivery System for Drug and Cell Therapy'
[patent_app_type] => utility
[patent_app_number] => 10/548213
[patent_app_country] => US
[patent_app_date] => 2004-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 14989
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0097/20110097385.pdf
[firstpage_image] =>[orig_patent_app_number] => 10548213
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/548213 | Delivery System for Drug and Cell Therapy | Mar 3, 2004 | Abandoned |
Array
(
[id] => 7263533
[patent_doc_number] => 20040241720
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Sodium activated potassium ion channel for therapeutic drug screening'
[patent_app_type] => new
[patent_app_number] => 10/787726
[patent_app_country] => US
[patent_app_date] => 2004-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 34768
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20040241720.pdf
[firstpage_image] =>[orig_patent_app_number] => 10787726
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/787726 | Sodium activated potassium ion channel for therapeutic drug screening | Feb 25, 2004 | Abandoned |
Array
(
[id] => 5677849
[patent_doc_number] => 20060183205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-17
[patent_title] => 'Method for controlling molecular weight and distribution of biopolymers'
[patent_app_type] => utility
[patent_app_number] => 10/544025
[patent_app_country] => US
[patent_app_date] => 2004-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4562
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20060183205.pdf
[firstpage_image] =>[orig_patent_app_number] => 10544025
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/544025 | Method for controlling molecular weight and distribution of biopolymers | Jan 28, 2004 | Abandoned |
Array
(
[id] => 7424368
[patent_doc_number] => 20040208848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-21
[patent_title] => 'Multi-antigenic alphavirus replicon particles and methods'
[patent_app_type] => new
[patent_app_number] => 10/735601
[patent_app_country] => US
[patent_app_date] => 2003-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 17572
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 194
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20040208848.pdf
[firstpage_image] =>[orig_patent_app_number] => 10735601
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/735601 | Multi-antigenic alphavirus replicon particles and methods | Dec 11, 2003 | Abandoned |
Array
(
[id] => 7677178
[patent_doc_number] => 20040152648
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-05
[patent_title] => 'Pyruvate-kinase as a novel target molecule'
[patent_app_type] => new
[patent_app_number] => 10/478679
[patent_app_country] => US
[patent_app_date] => 2003-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 4671
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20040152648.pdf
[firstpage_image] =>[orig_patent_app_number] => 10478679
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/478679 | Pyruvate-kinase as a novel target molecule | Nov 23, 2003 | Abandoned |
Array
(
[id] => 5710515
[patent_doc_number] => 20060051860
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'Method of organ regeneration'
[patent_app_type] => utility
[patent_app_number] => 10/535086
[patent_app_country] => US
[patent_app_date] => 2003-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 6408
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0051/20060051860.pdf
[firstpage_image] =>[orig_patent_app_number] => 10535086
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/535086 | Method of organ regeneration | Nov 16, 2003 | Abandoned |
Array
(
[id] => 7363992
[patent_doc_number] => 20040091891
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-13
[patent_title] => 'Novel enzymes and genes coding for the same derived from methylophilus methylotrophus'
[patent_app_type] => new
[patent_app_number] => 10/416021
[patent_app_country] => US
[patent_app_date] => 2003-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3929
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0091/20040091891.pdf
[firstpage_image] =>[orig_patent_app_number] => 10416021
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/416021 | Novel enzymes and genes coding for the same derived from methylophilus methylotrophus | Nov 11, 2003 | Abandoned |
Array
(
[id] => 7364641
[patent_doc_number] => 20040091996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-13
[patent_title] => 'Virus which can express tumor angiostatin factor with high efficiency in specific tumor cells and the use of it'
[patent_app_type] => new
[patent_app_number] => 10/432364
[patent_app_country] => US
[patent_app_date] => 2003-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 13846
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0091/20040091996.pdf
[firstpage_image] =>[orig_patent_app_number] => 10432364
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/432364 | Virus which can express tumor angiostatin factor with high efficiency in specific tumor cells and the use of it | Nov 5, 2003 | Abandoned |
Array
(
[id] => 5674136
[patent_doc_number] => 20060179491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => 'Process for treating non-human animals'
[patent_app_type] => utility
[patent_app_number] => 10/531531
[patent_app_country] => US
[patent_app_date] => 2003-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5081
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0179/20060179491.pdf
[firstpage_image] =>[orig_patent_app_number] => 10531531
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/531531 | Process for treating non-human animals | Oct 26, 2003 | Abandoned |
Array
(
[id] => 7474596
[patent_doc_number] => 20040055023
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-18
[patent_title] => 'Joint utilization of the insulin gene and the glucokinase gene in the development of therapeutic approaches for diabetes mellitus'
[patent_app_type] => new
[patent_app_number] => 10/451091
[patent_app_country] => US
[patent_app_date] => 2003-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4145
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20040055023.pdf
[firstpage_image] =>[orig_patent_app_number] => 10451091
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/451091 | Joint utilization of the insulin gene and the glucokinase gene in the development of therapeutic approaches for diabetes mellitus | Oct 19, 2003 | Abandoned |
Array
(
[id] => 7216209
[patent_doc_number] => 20040071678
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-15
[patent_title] => 'Method of producing genetically modified astrocytes and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/674598
[patent_app_country] => US
[patent_app_date] => 2003-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 6553
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0071/20040071678.pdf
[firstpage_image] =>[orig_patent_app_number] => 10674598
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/674598 | Method of producing genetically modified astrocytes and uses thereof | Sep 29, 2003 | Abandoned |
Array
(
[id] => 8591489
[patent_doc_number] => 08349364
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-08
[patent_title] => 'Nucleic acid coated particles suitable for temporary storage'
[patent_app_type] => utility
[patent_app_number] => 10/529010
[patent_app_country] => US
[patent_app_date] => 2003-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13901
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10529010
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/529010 | Nucleic acid coated particles suitable for temporary storage | Sep 28, 2003 | Issued |
Array
(
[id] => 7251829
[patent_doc_number] => 20050074752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-07
[patent_title] => 'Synthetic hepatitis C genes'
[patent_app_type] => utility
[patent_app_number] => 10/664391
[patent_app_country] => US
[patent_app_date] => 2003-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 5870
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20050074752.pdf
[firstpage_image] =>[orig_patent_app_number] => 10664391
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/664391 | Synthetic hepatitis C genes | Sep 16, 2003 | Abandoned |
Array
(
[id] => 7467886
[patent_doc_number] => 20040053877
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-18
[patent_title] => 'Paramyxovirus vector for transfering foreign gene into skeletal muscle'
[patent_app_type] => new
[patent_app_number] => 10/398598
[patent_app_country] => US
[patent_app_date] => 2003-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 11873
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20040053877.pdf
[firstpage_image] =>[orig_patent_app_number] => 10398598
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/398598 | Paramyxovirus vector for transfering foreign gene into skeletal muscle | Sep 11, 2003 | Abandoned |
Array
(
[id] => 7354913
[patent_doc_number] => 20040048800
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-11
[patent_title] => 'Use of vascular endothelial growth factor in the treatment of erectile dysfunction'
[patent_app_type] => new
[patent_app_number] => 10/658991
[patent_app_country] => US
[patent_app_date] => 2003-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9055
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20040048800.pdf
[firstpage_image] =>[orig_patent_app_number] => 10658991
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/658991 | Use of vascular endothelial growth factor in the treatment of erectile dysfunction | Sep 8, 2003 | Abandoned |
Array
(
[id] => 7355067
[patent_doc_number] => 20040048819
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-11
[patent_title] => 'Complexes for transferring nucleic acids into cells'
[patent_app_type] => new
[patent_app_number] => 10/398561
[patent_app_country] => US
[patent_app_date] => 2003-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9094
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 28
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20040048819.pdf
[firstpage_image] =>[orig_patent_app_number] => 10398561
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/398561 | Complexes for transferring nucleic acids into cells | Sep 4, 2003 | Abandoned |
Array
(
[id] => 5834608
[patent_doc_number] => 20060246438
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-02
[patent_title] => 'Methods for the chemical and physical modification of nanotubes, methods for linking the nanotubes, methods for the directed positioning of nanotubes, and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/526050
[patent_app_country] => US
[patent_app_date] => 2003-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 28940
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0246/20060246438.pdf
[firstpage_image] =>[orig_patent_app_number] => 10526050
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/526050 | Methods for the chemical and physical modification of nanotubes, methods for linking the nanotubes, methods for the directed positioning of nanotubes, and uses thereof | Aug 28, 2003 | Abandoned |